Cargando…
Effectiveness of mRNA COVID-19 vaccines against Omicron and Delta variants in a matched test-negative case–control study among US veterans
OBJECTIVE: To estimate the effectiveness of messenger RNA (mRNA) booster doses during the period of Delta and Omicron variant dominance. DESIGN: We conducted a matched test-negative case–control study to estimate the vaccine effectiveness (VE) of three and two doses of mRNA vaccines against infectio...
Autores principales: | Young-Xu, Yinong, Zwain, Gabrielle M, Izurieta, Hector S, Korves, Caroline, Powell, Ethan I, Smith, Jeremy, Balajee, Abirami, Holodniy, Mark, Beenhouwer, David O, Rodriguez-Barradas, Maria C, Brown, Sheldon T, Marconi, Vincent C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352567/ https://www.ncbi.nlm.nih.gov/pubmed/35922100 http://dx.doi.org/10.1136/bmjopen-2022-063935 |
Ejemplares similares
-
Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis
por: Korves, Caroline, et al.
Publicado: (2022) -
Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans
por: Young-Xu, Yinong, et al.
Publicado: (2021) -
Tixagevimab/cilgavimab for preventing COVID-19 during the Omicron surge: retrospective analysis of National Veterans Health Administration electronic data
por: Young-Xu, Yinong, et al.
Publicado: (2023) -
Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021
por: Young-Xu, Yinong, et al.
Publicado: (2021) -
702. Risk Factors for Acute Gastroenteritis Among Patients Hospitalized in 5 Veterans Affairs Medical Centers, 2016–19
por: Balachandran, Neha, et al.
Publicado: (2021)